Pos

Glycaemic care inpatient (For non critically ill)

Glycaemic care inpatient (For non critically ill)

Source: Practical Guide To Inpatient Glycemic Care 2020, MEMS MOH

Introduction

Insulin is the preferred choice for pharmacological therapy for hospitalised patients

In hospitalised patients,

  • Hyperglycaemia is defined as BG > 7.8mmol/L
  • Hypoglycaemia is defined as BG < 4.0mmol/L
  • HbA1c ≥ 6.3% suggests pre-existing diabetes

Recommendations

  • Inpatient glycaemic target, ICU and non-ICU is 7.8 - 10mmol/L
  • Insulin should be initiated once BG persistently ≥ 10mmol/L
  • In selected patients, stricter target of 6.1 - 7.8mmol/L can be considered while avoiding hypoglycaemia

Ways of lowering BG

  1. Variable rate intravenous insulin infusion (VRIII) - NBM (may cause iatrogenic hypokalaemia)
  2. Scheduled subcutaneous insulin – basal bolus/prandial regimen - Tolerating oraly (efective and no danger iatrogenic hypokalaemia)
  3. Scheduled subcutaneous insulin – basal plus regimen - NBM (no danger iatrogenic hypokalaemia)

algorithm.pngAlgorithm insulin

Variable rate intravenous insulin infusion (VRIII)

  • for NBM patient
  • dose as per VRIII Dosing Protocol (Sliding scale table)
  • initially use the standard rate of the scale

Adjustment of scale when

  • BG persistently >10mmol/L (on 2 readings) (switch to higher scale)
  • The initial BG is >20mmol/L and not falling by 3-5 mmol/L/hour (switch to higher scale)
  • BG control is too tight (4-6 mmol/L) or episode of hypoglycaemia, (either switch to a lower scale or increase dextrose in drip).

How to endorse (Example)

50 units of human rapid acting insulin is drawn up an added to 49.5 ml of sodium chloride in a 50 ml syringe and mixed thoroughly (1 unit insulin = 1 ml)

  • IVI Actrapid 50 units in 50 mL NS, 2 mL/hr
  • IVI Actrapid 50 units in 50 mL NS per sliding scale

sliding-scale.pngSliding scale

Scheduled subcutaneous insulin - basal bolus/prandial regimen

  • once tolerating orally
  • dose as per body weight (Total daily dose table)
  • correction doses (Top up scale table) can be given (only for fast acting insulin) if pre-meal or in between meal BG is elevated/not at target
  • 1 basal, 1-3 bolus (for meal) and correction dose
  • Total daily dose (TDD) is divided into 50% basal and 50% prandial insulin.

How to endorse (Example)

Elderly, 60 kg TDD = 0.3 U/kg/day × 60 kg = 18 units/day Basal (50%) = 9 units Prandial (50%) = 9 units → 3 units per meal

  • S/C Insulatard 9 units ON
  • S/C Actrapid 3 units TDS, top up scale B

tdd.pngTotal daily dose

topup-scale.pngTop up scale

Scheduled subcutaneous insulin – basal plus regimen

  • for NBM patient or poor oral intake
  • Calculate TDD as in Total Daily Dose
  • Administer basal insulin as above
  • Give correction dose of short acting insulin 6 hourly using Scale A in Top up scale
  • 1 basal and correction dose

How to endorse (Example)

Elderly, 60 kg TDD = 0.3 U/kg/day × 60 kg = 18 units/day Basal (50%) = 9 units Correction (50%) = 9 units → 2 units per shot

  • S/C Insulatard 9 units ON
  • S/C Actrapid 3 units QID, top up scale A

Oral anti-diabetic (OAD) medications

If patient are

  • Clinically stable
  • Good glycaemic control prior to admission
  • Allowed and taking orally well
  • No contraindications for use of OAD medications

How to endorse (example)

  • T. Metformin 500mg BD
  • T. Gliclazide 80mg OD
  • T. Vildagliptin 50mg BD with T. Metformin 500mg BD
  • T. Vildagliptin 50mg OD with T. Gliclazide 80mg OD

oad-meds.pngOAD Meds

Pos ini dilesenkan di bawah CC BY 4.0 oleh penulis.